Alcon Operating Income 2019-2024 | ALC

Alcon annual/quarterly operating income history and growth rate from 2019 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Alcon operating income for the quarter ending September 30, 2024 was $0.332B, a 13.31% increase year-over-year.
  • Alcon operating income for the twelve months ending September 30, 2024 was $1.226B, a 43.9% increase year-over-year.
  • Alcon annual operating income for 2023 was $1.039B, a 54.61% increase from 2022.
  • Alcon annual operating income for 2022 was $0.672B, a 15.86% increase from 2021.
  • Alcon annual operating income for 2021 was $0.58B, a 220.33% decline from 2020.
Alcon Annual Operating Income
(Millions of US $)
2023 $1,039
2022 $672
2021 $580
2020 $-482
2019 $-187
2018 $-248
Alcon Quarterly Operating Income
(Millions of US $)
2024-09-30 $332
2024-06-30 $318
2024-03-31 $368
2023-12-31 $208
2023-09-30 $293
2023-06-30 $270
2023-03-31 $268
2022-12-31 $21
2022-09-30 $205
2022-06-30 $200
2022-03-31 $246
2021-12-31 $182
2021-09-30 $20
2021-06-30 $229
2021-03-31 $149
2020-12-31 $141
2020-09-30 $-129
2020-06-30 $-466
2020-03-31 $-28
2019-12-31 $-68
2019-09-30 $-18
2019-06-30 $-53
2019-03-31 $-48
2018-12-31
2018-09-30 $-284
2018-06-30 $38
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $43.825B $9.455B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.584B 24.71
Intuitive Surgical (ISRG) United States $193.049B 100.93
Edwards Lifesciences (EW) United States $42.082B 26.72
IQVIA Holdings (IQV) United States $36.452B 20.08
IDEXX Laboratories (IDXX) United States $34.535B 40.67
DexCom (DXCM) United States $30.463B 45.88
Waters (WAT) United States $22.843B 33.78
STERIS (STE) Ireland $21.623B 24.89
SONOVA HOLDING (SONVY) Switzerland $20.352B 0.00
Hologic (HOLX) United States $18.042B 19.49
Sysmex ADR (SSMXY) Japan $13.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.922B 13.27
Globus Medical (GMED) United States $11.657B 29.52
Penumbra (PEN) United States $9.369B 91.77
Masimo (MASI) United States $9.238B 44.70
Teleflex (TFX) United States $8.957B 14.28
Glaukos (GKOS) United States $7.920B 0.00
PROCEPT BioRobotics (PRCT) United States $4.988B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.329B 99.88
Inari Medical (NARI) United States $3.040B 0.00
TransMedics (TMDX) United States $2.910B 92.25
LivaNova (LIVN) United Kingdom $2.851B 16.46
Nihon Kohden (NHNKY) Japan $2.276B 17.29
Elekta AB (EKTAY) Sweden $2.261B 20.33
Tandem Diabetes Care (TNDM) United States $2.012B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.889B 0.00
Alphatec Holdings (ATEC) United States $1.486B 0.00
Pulse Biosciences (PLSE) United States $1.316B 0.00
Artivion (AORT) United States $1.237B 82.00
OPKO Health (OPK) United States $1.051B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.881B 14.97
Paragon 28 (FNA) United States $0.863B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.746B 0.00
IRadimed (IRMD) United States $0.683B 36.94
Mesa Laboratories (MLAB) United States $0.636B 15.00
OrthoPediatrics (KIDS) United States $0.629B 0.00
AxoGen (AXGN) United States $0.612B 0.00
SiBone (SIBN) United States $0.569B 0.00
Treace Medical Concepts (TMCI) United States $0.531B 0.00
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Semler Scientific (SMLR) United States $0.473B 27.82
Tactile Systems Technology (TCMD) United States $0.469B 25.38
Delcath Systems (DCTH) United States $0.380B 0.00
CVRx (CVRX) United States $0.372B 0.00
ClearPoint Neuro (CLPT) United States $0.341B 0.00
NeuroPace (NPCE) United States $0.316B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
Inogen (INGN) United States $0.231B 0.00
Accuray (ARAY) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
Alpha Tau Medical (DRTS) Israel $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.172B 0.00
Atossa Genetics (ATOS) United States $0.164B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.93
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
InspireMD (NSPR) Israel $0.077B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.072B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.031B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Neuronetics (STIM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.015B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00